We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
4576
DELISTED
Express, Inc.
EXPR
-5
Closed
JT
4577
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
-166
Closed -$3K
KERNW
4578
DELISTED
Akerna Corp Warrant
KERNW
$0 ﹤0.01%
8
ALYA
4579
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$0 ﹤0.01%
56
-386
-87% -$1.03K
NVTA
4580
DELISTED
Invitae Corporation
NVTA
-30
Closed -$1K
GOL
4581
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-5,649
Closed -$87K
SFE
4582
DELISTED
Safeguard Scientifics, Inc.
SFE
-204
Closed -$2K
SRT
4583
DELISTED
Startek Inc.
SRT
-2,289
Closed -$15K
LTHM
4584
DELISTED
Livent Corporation
LTHM
-13,380
Closed -$90K
LVOX
4585
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
-400
Closed -$4K
FRTX
4586
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-25
Closed -$5K
VAPO
4587
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-557
Closed -$42K
NM
4588
DELISTED
Navios Maritime Holdings Inc.
NM
-248
Closed -$1K
ARCE
4589
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
-226
Closed -$11K
CWBR
4590
DELISTED
CohBar, Inc. Common Stock
CWBR
-184
Closed -$7K
VMW
4591
DELISTED
VMware, Inc
VMW
-1,376
Closed -$206K
SCU
4592
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-3,264
Closed -$64K
NXGN
4593
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-19
Closed
ICPT
4594
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-550
Closed -$36K
TWNK
4595
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-88
Closed -$1K
FRGI
4596
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-4,183
Closed -$44K
SVVC
4597
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$0 ﹤0.01%
75
-795
-91% -$5.25K
SCPL
4598
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
-122
Closed -$1K
CHNA
4599
DELISTED
Loncar China BioPharma ETF
CHNA
-44
Closed -$1K
CIR
4600
DELISTED
CIRCOR International, Inc
CIR
-1,371
Closed -$52K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.